March 14 (Reuters) - Reckitt RKT.L said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a case that accused the London-listed firm and Abbott ABT.N of failing to warn of the risks of premature-infant formulas.
The Thursday's ruling comes after a St. Louis, Missouri state court last October found Reckitt unit Mead Johnson and Abbott not responsible for a young boy's debilitating intestinal disease.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Anil D'Silva)
((abyjose.koilparambil@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。